Remdesivir Priced At More Than $3,100 For A Course Of Treatment

Gilead Sciences, maker of the antiviral drug remdesivir, has come up with a price for the COVID-19 treatment that was less than some analysts expected.

An experimental COVID-19 medicine that has been shown to shorten the time people with severe illness have to stay in the hospital finally has a price tag that's lower than some analysts expected.

(Image credit: ULRICH PERREY/POOL/AFP via Getty Images)

Comments

Popular posts from this blog

FIVE SIGNS YOUR TEEN MAY NEED TO BE EVALUATED FOR DEPRESSION

TAKE ACTION TO STOP BULLYING

GETTING BACK TO SCHOOL SAFELY